Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
MRK
|
Adam H Schechter
EVP & Pres-Global Human Health |
SELL
Open market or private sale
|
Indirect | 53,850 Reduced 31.64% |
$3,418,398
$63.48 p/Share
|
Apr 03
2017 |
|
NKE
|
Mark G Parker
EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 5.09% |
$5,550,000
$55.5 p/Share
|
Apr 03
2017 |
|
COF
|
Michael J Wassmer
President, Card |
SELL
Open market or private sale
|
Direct | 734 Reduced 0.91% |
$63,770
$86.88 p/Share
|
Apr 03
2017 |
|
PRTA
|
Dennis J. Selkoe |
SELL
Open market or private sale
|
Direct | 3,500 Reduced 55.16% |
$195,510
$55.86 p/Share
|
Apr 03
2017 |
|
TSLA
|
Kimbal Musk
Director |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 1.47% |
$717,075
$286.83 p/Share
|
Apr 03
2017 |
|
ORCL
|
Safra Catz
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 8,159 Reduced 1.74% |
$367,155
$45.0 p/Share
|
Apr 03
2017 |
|
AMT
|
William H Hess |
SELL
Open market or private sale
|
Direct | 90,489 Reduced 45.35% |
$10,968,172
$121.21 p/Share
|
Apr 03
2017 |
|
SPGI
|
Rebecca Jacoby
Director |
BUY
Open market or private purchase
|
Direct | 69 Added 12.83% |
$8,970
$130.01 p/Share
|
Apr 03
2017 |
|
ADBE
|
Bryan Lamkin
EVP, GM, Digital Media |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 27.75% |
$2,606,000
$130.3 p/Share
|
Mar 31
2017 |
|
IDCC
|
Scott A Mc Quilkin
Sr. EVP, Innovation |
SELL
Open market or private sale
|
Direct | 500 Reduced 0.62% |
$42,875
$85.75 p/Share
|
Mar 31
2017 |
|
BKGM
|
Francisco M. Atalig
SVP/Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 300 Reduced 15.19% |
$3,300
$11.0 p/Share
|
Mar 31
2017 |
|
AMP
|
Colin Moore
EVP & Global CIO |
SELL
Open market or private sale
|
Direct | 20,233 Reduced 26.78% |
$2,611,676
$129.08 p/Share
|
Mar 31
2017 |
|
ABT
|
Jaime Contreras
Senior Vice President |
SELL
Open market or private sale
|
Indirect | 767 Reduced 24.14% |
$34,239
$44.64 p/Share
|
Mar 31
2017 |
|
BKGM
|
Patricia Ann Perez Ada
Director |
BUY
Open market or private purchase
|
Direct | 271 Added 0.53% |
$2,981
$11.0 p/Share
|
Mar 31
2017 |
|
LLY
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct | 210,000 Reduced 0.17% |
$17,780,700
$84.67 p/Share
|
Mar 30
2017 |
|
ORCL
|
John F Fowler
EVP, Systems |
SELL
Open market or private sale
|
Direct | 250,000 Reduced 92.71% |
$11,165,000
$44.66 p/Share
|
Mar 30
2017 |
|
DJCO
|
John Patrick Et Al Guerin
Director |
SELL
Open market or private sale
|
Indirect | 1,397 Reduced 0.95% |
$293,412
$210.03 p/Share
|
Mar 30
2017 |
|
NVDA
|
Ajay K Puri
EVP, Worldwide Field Ops |
SELL
Open market or private sale
|
Direct | 133,542 Reduced 19.2% |
$14,493,313
$108.53 p/Share
|
Mar 30
2017 |
|
LOW
|
Marshall A Croom
EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 12,700 Reduced 23.75% |
$1,043,178
$82.14 p/Share
|
Mar 30
2017 |
|
MEDS
|
Donald G. Fell
Director |
BUY
Open market or private sale
|
Direct | 4 Added 0.31% |
$1
$0.25 p/Share
|
Mar 30
2017 |
|
SQ
|
Sarah Friar
Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 19,200 Reduced 20.0% |
$333,120
$17.35 p/Share
|
Mar 29
2017 |
|
NKE
|
Eric D Sprunk
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 16.66% |
$2,850,000
$57.0 p/Share
|
Mar 29
2017 |
|
ARE
|
James P Cain
Director |
SELL
Open market or private sale
|
Direct | 250 Reduced 7.4% |
$27,385
$109.54 p/Share
|
Mar 29
2017 |
|
AMT
|
Edmund Di Santo |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 9.56% |
$1,811,700
$120.78 p/Share
|
Mar 29
2017 |
|
HOFD
|
Jefferies Financial Group Inc. |
BUY
Open market or private purchase
|
Direct | 14,008 Added 0.13% |
$602,344
$43.0 p/Share
|
Mar 29
2017 |
|
ORCL
|
Safra Catz
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 46,767 Reduced 9.19% |
$2,104,983
$45.01 p/Share
|
Mar 28
2017 |
|
CMCSA
|
Arthur R Block
EVP, GC and Secretary |
SELL
Open market or private sale
|
Direct | 4,044 Reduced 5.91% |
$149,426
$36.95 p/Share
|
Mar 28
2017 |
|
BMY
|
Lamberto Andreotti
Director |
SELL
Open market or private sale
|
Direct | 17,000 Reduced 1.72% |
$955,400
$56.2 p/Share
|
Mar 28
2017 |
|
SQ
|
Sarah Friar
Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 19,200 Reduced 16.67% |
$329,280
$17.15 p/Share
|
Mar 28
2017 |
|
RETA
|
Abb Vie Inc.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 450,000 Reduced 27.43% |
$10,125,000
$22.5 p/Share
|
Mar 28
2017 |
|
INTU
|
Henry Tayloe Stansbury
EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 1,871 Reduced 69.07% |
$222,181
$118.75 p/Share
|
Mar 28
2017 |
|
USB
|
James B Kelligrew
Vice Chair |
BUY
Open market or private purchase
|
Indirect | 10 Added 0.0% |
$290
$29.04 p/Share
|
Mar 28
2017 |
|
USB
|
James B Kelligrew
Vice Chair |
BUY
Open market or private purchase
|
Indirect | 6 Added 0.0% |
$155
$25.88 p/Share
|
Mar 28
2017 |
|
USB
|
James B Kelligrew
Vice Chair |
BUY
Open market or private purchase
|
Indirect | 55 Added 0.0% |
$2,902
$52.77 p/Share
|
Mar 28
2017 |
|
USB
|
James B Kelligrew
Vice Chair |
BUY
Open market or private purchase
|
Indirect | 8 Added 0.0% |
$184
$23.06 p/Share
|
Mar 28
2017 |
|
CMCSA
|
Arthur R Block
EVP, GC and Secretary |
SELL
Open market or private sale
|
Direct | 15,846 Reduced 16.31% |
$589,154
$37.18 p/Share
|
Mar 27
2017 |
|
BMY
|
Lamberto Andreotti
Director |
SELL
Open market or private sale
|
Direct | 17,000 Reduced 1.69% |
$954,380
$56.14 p/Share
|
Mar 27
2017 |
|
TMUS
|
Thomas Christopher Keys
Pres. MetroPCS |
SELL
Open market or private sale
|
Direct | 81,400 Reduced 18.69% |
$5,235,648
$64.32 p/Share
|
Mar 24
2017 |
|
ADI
|
Vincent Roche
Chair & CEO |
SELL
Open market or private sale
|
Direct | 47,400 Reduced 62.8% |
$3,877,320
$81.8 p/Share
|
Mar 24
2017 |
|
COST
|
James D Sinegal
Director |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 6.52% |
$8,317,500
$166.35 p/Share
|
Mar 24
2017 |
|
COST
|
James D Sinegal
Director |
SELL
Open market or private sale
|
Indirect | 50,000 Reduced 7.49% |
$8,317,500
$166.35 p/Share
|
Mar 24
2017 |
|
ORCL
|
Safra Catz
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 518,072 Reduced 52.87% |
$23,323,602
$45.02 p/Share
|
Mar 24
2017 |
|
CMCSA
|
Arthur R Block
EVP, GC and Secretary |
SELL
Open market or private sale
|
Direct | 10,215 Reduced 14.85% |
$380,407
$37.24 p/Share
|
Mar 24
2017 |
|
NKE
|
Eric D Sprunk
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 16.66% |
$2,783,500
$55.67 p/Share
|
Mar 24
2017 |
|
USB
|
James B Kelligrew
Vice Chair |
BUY
Open market or private purchase
|
Indirect | 3 Added 0.0% |
$157
$52.64 p/Share
|
Mar 24
2017 |
|
NKE
|
John C Lechleiter
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 3.37% |
$56,300
$56.3 p/Share
|
Mar 24
2017 |
|
VC
|
Robert Manzo
Director |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 24.18% |
$191,400
$95.7 p/Share
|
Mar 24
2017 |
|
HOFD
|
Jefferies Financial Group Inc. |
BUY
Open market or private purchase
|
Direct | 783,889 Added 6.74% |
$31,316,366
$39.95 p/Share
|
Mar 23
2017 |
|
CMCSA
|
Arthur R Block
EVP, GC and Secretary |
SELL
Open market or private sale
|
Direct | 12,303 Reduced 12.22% |
$455,211
$37.0 p/Share
|
Mar 23
2017 |
|
MYL
|
Laboratories Abbott
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 44,000,000 Reduced 63.08% |
$1,830,399,933
$41.6 p/Share
|
Mar 23
2017 |